Bosh sahifaFME • ETR
add
Fresenius Medical Care AG
Yopilish kursi
41,44 €
Kunlik diapazon
41,61 € - 42,45 €
Yillik diapazon
32,51 € - 42,60 €
Bozor kapitalizatsiyasi
12,19 mlrd EUR
Oʻrtacha hajm
360,77 ming
Narx/foyda
18,81
Dividend daromadliligi
2,82%
Asosiy maydon
ETR
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(EUR) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 4,76 mlrd | -3,57% |
Joriy xarajat | 750,20 mln | -13,23% |
Sof foyda | 213,03 mln | 152,55% |
Sof foyda marjasi | 4,48 | 161,99% |
Har bir ulushga tushum | 0,82 | 43,86% |
EBITDA | 761,73 mln | 1,44% |
Amaldagi soliq stavkasi | 30,62% | — |
Balans
Jami aktivlari
Jami passivlari
(EUR) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 1,37 mlrd | -11,74% |
Jami aktivlari | 32,51 mlrd | -8,77% |
Jami passivlari | 17,72 mlrd | -12,28% |
Umumiy kapital | 14,79 mlrd | — |
Tarqatilgan aksiyalar | 293,41 mln | — |
Narxi/balansdagi bahosi | 0,89 | — |
Aktivlardan daromad | 2,98% | — |
Kapitaldan daromad | 3,74% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(EUR) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | 213,03 mln | 152,55% |
Operatsiyalardan naqd pul | 984,71 mln | 29,61% |
Sarmoyadan naqd pul | -219,93 mln | -45,55% |
Moliyadan naqd pul | -477,08 mln | -15,70% |
Naqd pulning sof oʻzgarishi | 275,33 mln | 29,23% |
Boʻsh pul | 1,00 mlrd | 313,51% |
Haqida
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives.
With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan.
The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue.
The company is on the Best Employers List published by Forbes. Wikipedia
CEO
Tashkil etilgan
1996
Xodimlar soni
113 079